Clovis Oncology trustee forms unsecured creditors committee

Chicago, Dec. 22 – Clovis Oncology, Inc.’s Chapter 11 bankruptcy case has had an unsecured creditors committee appointed to it by Region 3 U.S. trustee Andrew R. Vara, according to a filing with the U.S. Bankruptcy Court for the District of Delaware.

The seven-member committee is comprised of Gary Bush representing Bank of New York Mellon Trust Co., NA, Marc Brotman representing Pfizer Inc., Wesley Roberts representing Syneous Health, Dave Mack representing Iqvia, Sean Diver representing Lonza Ltd., Jon Larson representing MDcentRx, LLC and Brenda Bishop representing EMB Statistical Solutions, LLC.

The trustee’s office also scheduled a creditors meeting for Jan. 12.

Clovis Oncology is a Boulder, Colo.-based biopharmaceutical company. The company filed bankruptcy on Dec. 11 under Chapter 11 case number 22-11292.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.